SIRA+P: Development and Testing

Kristina L Foster1, Lacey D Bergerhofer2, Janis B Smith2

  • 1Lucile Packard Children's Hospital Stanford, 725 Welch Rd, Palo Alto, CA 94304, United States.

Insights

The new Skin Injury Risk Assessment and Prevention (SIRA+P) scale demonstrates high reliability and validity across all ages for assessing skin injury risk. This tool aids nurses in preventing pressure injuries with EHR integration.

Area of Science:

  • Nursing
  • Patient Safety
  • Clinical Assessment Tools

Background:

  • Pressure injuries are a significant concern in healthcare, impacting patient outcomes and increasing costs.
  • Existing risk assessment scales may have limitations in applicability across diverse age groups and clinical settings.
  • The development of a comprehensive and reliable skin risk assessment tool is crucial for effective prevention strategies.

Purpose of the Study:

  • To introduce and evaluate the psychometric properties of the Skin Injury Risk Assessment and Prevention (SIRA+P) scale.
  • To establish the initial reliability and validity of the SIRA+P scale in a broad patient population, from neonates to adults.
  • To assess the SIRA+P scale's utility across various age groups and illness acuities.

Main Methods:

  • A retrospective chart review of 385 patients across all hospital units was conducted.
  • Concurrent validity was assessed by comparing SIRA+P with established scales: Neonatal Skin Risk Assessment Scale (NSRAS), Braden Q Scale (Braden Q), and Braden Scale.
  • Interrater reliability was determined using Intraclass Correlation Coefficients (ICC).

Main Results:

  • The SIRA+P scale exhibited very high interrater reliability (ICC = 0.878).
  • Strong correlations were found between SIRA+P and established scales: NSRAS (0.725), Braden Q (-0.634), and Braden (-0.778).
  • These results indicate good reliability and validity across the studied age spectrum.

Conclusions:

  • The SIRA+P scale is a reliable and valid tool for assessing skin injury risk in patients of all ages.
  • Designed for EHR integration, SIRA+P offers nursing decision support for targeted pressure injury prevention.
  • The scale's ability to account for device-related pressure enhances its clinical utility in preventing skin breakdown.
Abstract

Related Concept Videos

Preclinical Development: Overview01:28

Preclinical Development: Overview

Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
6.3K
In Vitro Drug Release Testing: Overview, Development and Validation01:10

In Vitro Drug Release Testing: Overview, Development and Validation

In vitro dissolution and drug release tests assess how quickly and how much of a drug is released from its dosage form into an aqueous medium under standardized laboratory conditions. These tests are essential tools in pharmaceutical development and quality assurance, offering insight into the drug's performance before clinical use.During formulation development, dissolution testing identifies incomplete or inconsistent drug release issues. It also supports decisions on selecting the optimal...
456
Quality Assurance01:19

Quality Assurance

Quality assurance is the overarching term used to describe the activities employed to ensure the proper performance of a system. These activities can be classified into three categories: quality control, quality assessment, and internal corrective measures. Typically, these activities work cyclically: quality control is performed before and during the analysis, while quality assessment occurs during and after the investigation. Internal corrective measures are implemented based on the findings...
3.7K
Clinical Trials: Overview01:11

Clinical Trials: Overview

Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
5.2K
Three Developmental Domains01:29

Three Developmental Domains

Human development is typically examined across three main domains: physical, cognitive, and socio-emotional. These domains represent the significant areas of change and continuity throughout the lifespan, from infancy to late adulthood.
Physical Development
Physical processes, also known as maturation, encompass the biological changes that occur across an individual's life. These changes begin with genetic inheritance and continue through various stages, including growth in height and weight,...
1.3K
Significance Testing: Overview01:04

Significance Testing: Overview

Significance testing is a set of statistical methods used to test whether a claim about a parameter is valid. In analytical chemistry, significance testing is used primarily to determine whether the difference between two values comes from determinate or random errors. The effect of a particular change in the measurement protocol, analyst, or sample itself can cause a deviation from the expected result. In the case of a suspected deviation/outlier, we need to be able to confirm mathematically...
12.9K